公开(公告)号：US20050123796A1

公开(公告)日：2005-06-09

申请号：US10729724

申请日：2003-12-05

Applicant: David Giesen ,  Richard Parton ,  Ching Tang

Inventor： David Giesen ,  Richard Parton ,  Ching Tang

IPC: C07C209/00 ,  C07C211/00 ,  C09K11/06 ,  H01L51/00 ,  H01L51/50 ,  H05B33/14

CPC classification number: H05B33/14 ,  C09K11/06 ,  C09K2211/1011 ,  C09K2211/1014 ,  C09K2211/1029 ,  C09K2211/1055 ,  C09K2211/1085 ,  C09K2211/1092 ,  C09K2211/1408 ,  C09K2211/185 ,  H01L51/0052 ,  H01L51/0059 ,  H01L51/0062 ,  H01L51/0081 ,  H01L51/0085 ,  H01L51/5016 ,  H01L2251/308

Abstract: Disclosed is an electroluminescent device comprising a cathode, an anode, and located therebetween a light emitting layer (LEL) containing (1) a host material that comprises a N,N,N′,N′-tetra-aromatic benzidine group substituted in at least one position ortho to the biphenyl linkage between the phenyl groups of the benzidine nucleus and (2) a phosphorescent light emitting material, wherein the triplet state energy of the benzidine nucleus is higher than the triplet state energy of the phosphorescent emitting material.

Abstract translation: 公开了一种电致发光器件，其包括阴极和阳极，并位于其间，包含（1）主体材料的发光层（LEL），所述主体材料包含在其中被取代的N，N，N'，N'-四 - 芳族联苯胺基团 与联苯胺核的苯基之间的联苯键相邻的至少一个位置和（2）磷光发光材料，其中联苯胺核的三重态能量高于磷光发光材料的三线态能量。

公开(公告)号：US20060099712A1

公开(公告)日：2006-05-11

申请号：US10983369

申请日：2004-11-08

Applicant: Paul Gilman ,  Richard Parton ,  Jerome Lenhard

Inventor： Paul Gilman ,  Richard Parton ,  Jerome Lenhard

IPC: G01N33/00

CPC classification number: C09B23/0075 ,  C09B23/06 ,  G01N27/4166

Abstract: The present invention relates to a method for selecting pharmacological compounds for selective inhibition of cancer cells comprising identifying a compound, determining the reduction potential (ER) of the compound, and selecting the compound which has a reduction potential from −1.1 to −0.8 volts. The invention also relates to a pharmacological compound comprising at least one cyanine dye or merocyanine dye, wherein the dye has at least one cationic substituent, wherein the dye has a reduction potential of from—1.1 to 0.8 volts, and wherein the pharmacological compound demonstrates selective inhibition of cancer cells.

Abstract translation: 本发明涉及选择性抑制癌细胞的药理化合物的选择方法，包括鉴定化合物，测定化合物的还原电位（E SUB R R），并选择具有还原电位的化合物 从-1.1到-0.8伏。 本发明还涉及包含至少一种花青染料或部花青染料的药理化合物，其中所述染料具有至少一个阳离子取代基，其中所述染料具有从1.1至0.8伏特的还原电位，并且其中所述药物化合物显示出选择性 抑制癌细胞。

公开(公告)号：US20050214567A1

公开(公告)日：2005-09-29

申请号：US10810282

申请日：2004-03-26

Applicant: Richard Parton ,  Wojciech Slusarek ,  Zbyslaw Owczarczyk ,  Ching Tang

Inventor： Richard Parton ,  Wojciech Slusarek ,  Zbyslaw Owczarczyk ,  Ching Tang

IPC: C09K11/06 ,  H01L51/00 ,  H01L51/50 ,  H05B33/12 ,  H05B33/14

CPC classification number: H01L51/006 ,  C09K11/06 ,  C09K2211/1011 ,  C09K2211/1014 ,  C09K2211/1029 ,  C09K2211/1033 ,  C09K2211/1037 ,  C09K2211/1055 ,  C09K2211/107 ,  C09K2211/1088 ,  H01L51/0052 ,  H01L51/0081 ,  H01L51/5048 ,  H01L2251/308 ,  H05B33/14

Abstract: An electroluminescent device comprises a layer containing a naphthalene compound represented by Formula (1), wherein: each R1 and R2 represents an independently selected substituent provided that adjacent substituents may join to form a ring; p and w independently are 0-3; the amine nitrogens on the naphthalene nucleus are located on separate rings; m and n independently are 0, 1 or 2; each Arb represents an independently selected aromatic group; and each Ara represents an independently selected phenylene, biphenylene or naphthalene group; provided that at least one R1 or R2 substituent of the naphthalene compound represented by Formula (1) is a sterically bulky substituent.

Abstract translation: 电致发光器件包括含有由式（1）表示的萘化合物的层，其中：每个R 1和R 2代表独立选择的取代基，条件是相邻的取代基可以连接 形成一个戒指; p和w独立地为0-3; 萘核上的胺氮位于分离的环上; m和n独立地为0,1或2; 每个Ar B代表独立选择的芳基; 每个Ar a a表示独立选择的亚苯基，亚联苯基或萘基; 条件是由式（1）表示的萘化合物的至少一个R 1或R 2取代基是空间庞大的取代基。